Cardiovascular
EndurAnt Stent Graft system vs ExcluDer endoprothesis: a global, prospectiVe, rANdomized Clinical trial in sac rEgression (ADVANCE Study) (ADVANCE)
The ADVANCE study is post-market, prospective, interventional, global,
multicenter, randomized, dual-arm trial.
The purpose of the post-market study is to demonstrate clinical benefit with Endurant II/IIs compared to Gore Excluder/Excluder Conformable by generating robust, Level I evidence to elucidate the mechanism of sac regression and any device-related differences, in subjects with Abdominal Aortic Aneurysms (AAA) for whom an EVAR procedure is indicated. Beyond comparing sac regression rates between devices, the study will also investigate if the sac regression led to decreased risk ...
GO TO STUDY